Arya Aminorroaya, MD, MPH
Hospital ResidentAbout
Research
Publications
2026
Wearable Devices and Data Sharing in the US
Pedroso A, Dhingra L, Aminorroaya A, Khera R. Wearable Devices and Data Sharing in the US. JAMA Network Open 2026, 9: e2617733. PMID: 42268609, PMCID: PMC13254737, DOI: 10.1001/jamanetworkopen.2026.17733.Peer-Reviewed Original ResearchConceptsHealth Information National Trends SurveyPopulation-based surveyUS adultsWearable device useSociodemographic subgroupsCardiovascular diseaseCommunity-dwelling US adultsRisk factorsWearable useNational Trends SurveyDevice useHealth care toolCVD risk factorsSurvey studyUS adult populationPotential of wearable devicesWearable dataPersonal health informationDaily useSharing of personal health informationAssociated with greater willingnessSubgroups of ageData sharingWearable devicesTrends SurveyCorrection: Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran
Farrokhpour H, Nasserinejad M, Ahmadi N, Golestani A, Keykhaei M, Azadnajafabad S, Aminorroaya A, Naderian M, Rezaei N, Djalalinia S, Farzi Y, Rashidi M, Rezaei N, Ghasemi E, Abdolhamidi E, Yoosefi M, Kazemi A, Haghshenas R, Majnoon M, Farzadfar F. Correction: Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran. Scientific Reports 2026, 16: 13774. PMID: 42056179, PMCID: PMC13129002, DOI: 10.1038/s41598-026-50915-2.Peer-Reviewed Original ResearchAssociation of Vitamin B12 and Folate Deficiency with Vasovagal Syncope: A Case-Control Study
Aminorroaya A, Vasheghani-Farahani A, Tavolinejad H, Aryan Z, Yadangi S, Bozorgi A, Sadeghian S, Boroumand M, Yunesian M, Tajdini M. Association of Vitamin B12 and Folate Deficiency with Vasovagal Syncope: A Case-Control Study. The Journal Of Tehran University Heart Center 2026 DOI: 10.18502/jthc.v21i1.21279.Peer-Reviewed Original ResearchSerum vitamin B12 levelsFrequent vasovagal syncopeAssociation of vitamin B12Vitamin B12 levelsVasovagal syncopeCase-control studyFolate deficiencySerum levelsB12 levelsVitamin B12Case groupLow serum vitamin B12 levelsHead-up tilt table testVitamin B12 deficiencySerum vitamin B12Sex-matched individualsTilt table testingVitamin B supplementationSyncope historyPediatric patientsSleeve gastrectomyAdult patientsB12 deficiencyHomocysteine levelsClinical evidenceComparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
Bu F, Wu R, Ostropolets A, Aminorroaya A, Chen H, Chai Y, Dhingra L, Falconer T, Hsu J, Kim C, Lau W, Man K, Minty E, Morales D, Nishimura A, Thangraraj P, Van Zandt M, Yin C, Khera R, Hripcsak G, Suchard M. Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus. Journal Of The American College Of Cardiology 2026, 87: 2963-2977. PMID: 41984016, PMCID: PMC13191718, DOI: 10.1016/j.jacc.2026.02.5123.Peer-Reviewed Original ResearchSodium-glucose cotransporter 2 inhibitorsGlucagon-like peptide 1 receptor agonistsPeptide 1 receptor agonistsComparative effectiveness assessmentCompare cardiovascular effectsCardiovascular diseaseGLP-1RACardiovascular effectsElectronic health record databaseSodium-glucoseRandom-effects meta-analysisGLP-1RAsHealth record databaseCardiovascular benefitsCardiovascular disease subgroupsCox proportional hazards modelsEstablished cardiovascular diseaseSecondary subgroup analysisSecond-line therapyEffects of glucagon-like peptide 1 receptor agonistsMeta-analytic estimatesProportional hazards modelType 2 diabetes mellitusCardiovascular outcome trialsPropensity score adjustmentReal-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes
Kim C, Bu F, Blacketer C, Ostropolets A, Duarte-Salles T, Viernes B, Falconer T, Pistillo A, Li J, Yin C, Van Zandt M, Nagy P, Nishimura A, Minty E, You S, Sawano M, Sawano S, Jeon J, Aminorroaya A, Dhingra L, Pedroso A, Thangaraj P, Dorr D, Pratt N, Man K, Lau W, Morales D, Khera R, Schuemie M, Ryan P, Hripcsak G, Krumholz H, Suchard M, Lu Y. Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes. Nature Communications 2026 PMID: 41935054, DOI: 10.1038/s41467-026-71307-0.Peer-Reviewed Original ResearchGLP-1 receptor agonistsReceptor agonistsAntihyperglycemic agentsGLP-1SGLT2 inhibitorsClinical trialsComparative safetyRisk of diabetic ketoacidosisHigh riskHigher risk of diabetic ketoacidosisRisk of peripheral edemaMultinational cohort studyRisk of hypoglycemiaDPP-4 inhibitorsPropensity score adjustmentType 2 diabetesPeripheral edemaDiabetic ketoacidosisAdverse eventsCohort studyHazard ratioDPP-4Safety outcomesAgonistsReal-world evidence26-A-20737-ACC MULTIMODAL RETRIEVAL-AUGMENTED SYSTEM FOR INTEROPERABLE ASSESSMENT OF THROMBOEMBOLIC AND BLEEDING RISK IN ATRIAL FIBRILLATION
Adejumo P, Thangaraj P, Dhingra L, Biswas D, Aminorroaya A, Shankar S, Pedroso A, Croon P, Khera R. 26-A-20737-ACC MULTIMODAL RETRIEVAL-AUGMENTED SYSTEM FOR INTEROPERABLE ASSESSMENT OF THROMBOEMBOLIC AND BLEEDING RISK IN ATRIAL FIBRILLATION. Journal Of The American College Of Cardiology 2026, 87: a95. DOI: 10.1016/j.jacc.2026.02.236.Peer-Reviewed Original Research26-YIA-7947-ACC AI-ENHANCED ECG ANALYSIS ENABLED DISCOVERY OF MECHANISTIC PATHWAYS FOR DRUG-INDUCED LONG QT SYNDROME
Biswas D, Aminorroaya A, Choi R, Dhingra L, Khera R. 26-YIA-7947-ACC AI-ENHANCED ECG ANALYSIS ENABLED DISCOVERY OF MECHANISTIC PATHWAYS FOR DRUG-INDUCED LONG QT SYNDROME. Journal Of The American College Of Cardiology 2026, 87: a1955. DOI: 10.1016/j.jacc.2026.02.4868.Peer-Reviewed Original ResearchEpidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran
Farrokhpour H, Nasserinejad M, Ahmadi N, Golestani A, Keykhaei M, Azadnajafabad S, Aminorroaya A, Naderian M, Rezaei N, Djalalinia S, Farzi Y, Rashidi M, Rezaei N, Ghasemi E, Abdolhamidi E, Yoosefi M, Kazemi A, Haghshenas R, Majnoon M, Farzadfar F. Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran. Scientific Reports 2026, 16: 10825. PMID: 41896642, PMCID: PMC13039966, DOI: 10.1038/s41598-026-45344-0.Peer-Reviewed Original ResearchConceptsCardiometabolic careAtherosclerotic cardiovascular disease riskAtherosclerotic cardiovascular diseaseCardiovascular healthCardiovascular health metricsStep studyAHA/ACC Pooled Cohort EquationsPooled Cohort EquationsDiabetes mellitusCross-sectional analysisCohort EquationsCondition prevalenceASCVD riskAtherosclerotic cardiovascular disease groupHealth burdenCareASCVD prevalenceStatin useCardiovascular diseaseCause of mortalityLipid goalsRisk groupsHypertension targetsPrevalenceAdultsWearable-Echo-FM: an ECG echo foundation model for 1-lead electrocardiography
Knight E, Oikonomou E, Aminorroaya A, Pedroso A, Khera R. Wearable-Echo-FM: an ECG echo foundation model for 1-lead electrocardiography. European Heart Journal - Digital Health 2026, 7: ztag049. PMID: 42077383, PMCID: PMC13131981, DOI: 10.1093/ehjdh/ztag049.Peer-Reviewed Original ResearchConvolutional neural networkArtificial intelligenceBaseline convolutional neural networkContrastive pre-trainingPortable devicesHeld-out test setText encoderNeural networkWearable electrocardiogramPre-trainingTraining setText reportsTest setWearableStructural heart diseaseLeft ventricular systolic dysfunctionEncodingDevicesIntelligenceNetworkLabelingSetsArtificial Intelligence-enhanced Electrocardiography for Heart Failure Screening and Risk Stratification
Dhingra L, Croon P, Batinica B, Aminorroaya A, Pedroso A, Khera R. Artificial Intelligence-enhanced Electrocardiography for Heart Failure Screening and Risk Stratification. Current Heart Failure Reports 2026, 23: 10. PMID: 41838300, DOI: 10.1007/s11897-026-00748-x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRisk factor surveillancePublic health challengeHeart failure screeningHF risk assessmentHF screeningRoutine careCommunity programsHF riskHealth challengesECG testRisk scoreECG interpretationRisk stratificationConfirmatory imagingSymptom onsetRiskCost-effectiveClinical implementationProspective validationScreeningTherapy decisionsFunctional abnormalitiesCareRisk assessmentCohort
Academic Achievements & Community Involvement
News & Links
News
- April 28, 2026
Choosing Safer Diabetes Medications for Older Adults
- March 16, 2026
Yale School of Medicine Faculty To Present New Cardiovascular Research at National Cardiology Conference
- February 11, 2026
Using AI to Guide AI
- December 12, 2025
Resident Roundup: Arya Aminorroaya, MD, MPH